Joan Antoni Fernández-Blanco
- Abediterol has higher bronchodilatory potency than other long-acting β2-receptor agonists in a guinea pig modelBy Jorge De Alba, Raquel Otal, Joan Antoni Fernández-Blanco, Mònica Aparici, Carlos Puig, Amadeu Gavaldà and Montserrat MiralpeixJorge De Alba1Almirall R&D Center, Almirall, S.A., Barcelona, SpainRaquel Otal1Almirall R&D Center, Almirall, S.A., Barcelona, SpainJoan Antoni Fernández-Blanco1Almirall R&D Center, Almirall, S.A., Barcelona, SpainMònica Aparici1Almirall R&D Center, Almirall, S.A., Barcelona, SpainCarlos Puig1Almirall R&D Center, Almirall, S.A., Barcelona, SpainAmadeu Gavaldà1Almirall R&D Center, Almirall, S.A., Barcelona, SpainMontserrat Miralpeix1Almirall R&D Center, Almirall, S.A., Barcelona, Spain
- Novel oral voltage-gated sodium channel (Nav) inhibitors inhibit capsaicin induced cough in conscious guinea pigsBy Monica Aparici, Jorge De Alba, Joan Antoni Fernández-Blanco, Silvia Fonquerna, Laia Sole, Israel Ramos, Marisa Vinyals, Sonia Sentellas, James Duffy, Gary Clark, Damian Bell and Montserrat MiralpeixMonica Aparici1R&D Centre, Almirall S.A., Sant Feliu de Llobregat, Barcelona SpainJorge De Alba1R&D Centre, Almirall S.A., Sant Feliu de Llobregat, Barcelona SpainJoan Antoni Fernández-Blanco1R&D Centre, Almirall S.A., Sant Feliu de Llobregat, Barcelona SpainSilvia Fonquerna1R&D Centre, Almirall S.A., Sant Feliu de Llobregat, Barcelona SpainLaia Sole1R&D Centre, Almirall S.A., Sant Feliu de Llobregat, Barcelona SpainIsrael Ramos1R&D Centre, Almirall S.A., Sant Feliu de Llobregat, Barcelona SpainMarisa Vinyals1R&D Centre, Almirall S.A., Sant Feliu de Llobregat, Barcelona SpainSonia Sentellas1R&D Centre, Almirall S.A., Sant Feliu de Llobregat, Barcelona SpainJames Duffy2Biofocus, Charles River Laboratories, Saffron Walden, Essex United KingdomGary Clark2Biofocus, Charles River Laboratories, Saffron Walden, Essex United KingdomDamian Bell2Biofocus, Charles River Laboratories, Saffron Walden, Essex United KingdomMontserrat Miralpeix1R&D Centre, Almirall S.A., Sant Feliu de Llobregat, Barcelona Spain
- Pharmacological profile of a novel, potent and oral TRPA1 antagonist. Characterization in a preclinical model of induced coughBy Mònica Aparici, Gema Tarrasón, Irene Jover, Carla Carcasona, Joan Antoni Fernández-Blanco, Peter Eichhorn, Amadeu Gavaldà, Jorge De Alba, Richard Roberts and Montserrat MiralpeixMònica ApariciR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, SpainGema TarrasónR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, SpainIrene JoverR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, SpainCarla CarcasonaR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, SpainJoan Antoni Fernández-BlancoR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, SpainPeter EichhornR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, SpainAmadeu GavaldàR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, SpainJorge De AlbaR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, SpainRichard RobertsR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, SpainMontserrat MiralpeixR&D Center, Almirall S.A., Sant Feliu de Llobregat, Barcelona, Spain
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.